Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
Bio-Techne Corporation (TECH) Q3 2023 Earnings Call Transcript
03:39pm, Wednesday, 03'rd May 2023
Bio-Techne Corporation (NASDAQ:TECH ) Q3 2023 Earnings Conference Call May 3, 2023 9:00 AM ET Company Participants David Clair – Vice President-Investor Relations Chuck Kummeth – Chief Executive O
Techne (TECH) Meets Q3 Earnings Estimates
09:07am, Wednesday, 03'rd May 2023
Techne (TECH) came out with quarterly earnings of $0.53 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.54 per share a year ago.
GSK or TECH: Which Is the Better Value Stock Right Now?
12:56pm, Friday, 28'th Apr 2023
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both GSK (GSK) and Techne (TECH). But which of these two companies is the best option for those looking f
7 Biotech Stocks That Could Cure Your Portfolio Woes
07:22pm, Wednesday, 19'th Apr 2023
Fundamentally, the driving catalyst for biotech stocks to buy centers on the possibility of supporting paradigm-shifting medical breakthroughs. For example, a report published by the JAMA Network indi
BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
07:00am, Friday, 10'th Mar 2023
MINNEAPOLIS , March 10, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the Barclays G
BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
09:58am, Tuesday, 28'th Feb 2023
MINNEAPOLIS , Feb. 28, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Cowen 43rd Annual Heal
Bio-Techne Corporation (TECH) Q2 2023 Earnings Call Transcript
11:51am, Thursday, 02'nd Feb 2023
Bio-Techne Corporation (NASDAQ:TECH ) Q2 2023 Earnings Conference Call February 2, 2023 9:00 AM ET Company Participants David Clair - Vice President of Investor Relations Chuck Kummeth - Chief Executi
Techne (TECH) Q2 Earnings and Revenues Miss Estimates
09:02am, Thursday, 02'nd Feb 2023
Techne (TECH) delivered earnings and revenue surprises of -4.08% and 6.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Mairs and Power Commments on Bio-Techne
06:00pm, Monday, 23'rd Jan 2023
Bio-Techne ( TECH , Financial) also suffered from a shift away from growth stocks by investors. Despite the company's fundamental outlook improving on a number of future growth initiatives, the stock
REGN or TECH: Which Is the Better Value Stock Right Now?
12:48pm, Wednesday, 11'th Jan 2023
REGN vs. TECH: Which Stock Is the Better Value Option?
GSK or TECH: Which Is the Better Value Stock Right Now?
12:47pm, Monday, 26'th Dec 2022
GSK vs. TECH: Which Stock Is the Better Value Option?
BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
07:00am, Wednesday, 21'st Dec 2022
MINNEAPOLIS , Dec. 21, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 41st Annual J.P. Morgan
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.
Our 7 Top Biotech Stock Picks for 2023
05:42pm, Friday, 09'th Dec 2022
If there's a silver lining regarding the coronavirus pandemic, it's that it demonstrated the importance of the top biotech stock picks for 2023. While medical innovations may seem frustratingly slow,
BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
07:00am, Monday, 28'th Nov 2022
MINNEAPOLIS , Nov. 28, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Fifth Annual Evercore I
